Reach de-identified patient and provider segments at scale across every channel.
Pharmaceutical brands and media platforms, including connected TV (CTV), can activate HIPAA-compliant audiences built on real-world clinical and claims data through a new collaboration between PurpleLab and Experian.
Targeting de-identified audiences is essential for engaging the right patients at pivotal moments in their health journey, maximizing ROI while safeguarding privacy and improving outcomes. Overall, prescription drugmakers spent $2.97 billion on national TV advertising in the first half of 2025, a 12.2% year-over-year increase, underscoring the growing demand for scalable, privacy-compliant healthcare advertising in premium media environments.
Now, whether you’re a pharma advertiser launching a new therapy or a platform curating health-focused inventory, PurpleLab’s integration refreshes the media planning ecosystem, offering marketers easier access to the audiences needed to drive impact.
Activate with accuracy and scale
PurpleLab’s de-identified healthcare segments, categorized by condition, treatment, specialty, and prescription behavior, are now accessible through Experian’s data marketplace, streamlining media planning. This integration enables PurpleLab’s privacy-safe audiences to travel from discovery to omnichannel delivery. Experian then handles onboarding, activation, and audience expansion, in accordance with HIPAA and with industry standards.
Utilizing Experian’s identity graph, spanning household and individual-level insights, as well as marketing attributes, these healthcare audiences can be:
- Onboarded securely, matching hashed emails or tokens to digital identifiers
- Activated across major channels, including CTV, mobile, display, and social
- Expanded with confidence, reaching more of the target population, patients, or healthcare professionals, without relying on third-party cookies
This infrastructure unlocks greater scale and completeness for niche pharma audiences that have historically been hard to reach in digital and streaming environments. For brands navigating fragmented media and tightening privacy regulations, this collaboration provides the clarity and consistency they’ve been seeking.
“We know healthcare marketers are under pressure to get it right: to respect privacy, be accurate, and scale. That’s why we’re excited to bring PurpleLab audiences into the Experian data marketplace and make them available through Audigent’s curated deals. It gives pharmaceutical brands and platforms a clear way to plan and measure campaigns, with the assurance that they’re reaching patients and providers when it matters in the right way.”
ExperianKim Gilberti, General Manager
Curation through Audigent: Premium supply meets premium data
For advertisers seeking turnkey media solutions, PurpleLab audiences are now also available through Audigent’s curated deals. Audigent’s curated deals simplify media buying by packaging PurpleLab’s clinically grounded audiences with premium, brand-safe inventory, thus creating a unified package.
Instead of stitching together data and supply separately, media buyers can now access pre-built or custom-curated media deals where PurpleLab audiences are already integrated, ideal for health and wellness programming, premium CTV, or contextual content aligned to therapeutic areas. This approach gives marketers both efficiency and accuracy, streamlining execution while maintaining compliance and relevance.
“Bringing together PurpleLab’s clinically precise audiences with Experian’s powerful identity and activation capabilities, and pairing it with Audigent’s premium inventory, gives advertisers more than a turnkey solution. It’s the power to launch campaigns that truly resonate, with data and media working in harmony from day one to deliver both efficiency and impact.”
PurpleLabScott Ronay, VP, Advertising Sales
Real-world use cases: Accuracy with purpose
CTV awareness for cardiovascular therapies
A cardiovascular brand is launching a CTV campaign to reach healthcare providers involved in treatment decisions. Using PurpleLab’s provider-level segments from the Experian data marketplace, a brand can activate audiences across brand-safe, streaming environments. This strategy enables meaningful engagement with prescribers while maintaining scale and compliance across CTV and complementary digital channels.
Cross-device activation for high-impact health campaigns
A biotech firm promoting a new therapy needs to reach patients who are likely to have a relevant condition, based on modeled audience segments. Using PurpleLab’s real-world patient segments, the advertiser activates across mobile, display, and CTV, with Experian’s identity graph ensuring household-level consistency across devices. Privacy and scale are preserved, while the brand ensures it’s not wasting impressions on ineligible or misaligned audiences.
Closed-loop measurement, built for healthcare
Beyond targeting, the PurpleLab–Experian integration empowers advertisers to measure real-world outcomes, not just digital proxies. By utilizing tokenization, Experian enables ad exposure data to be securely matched back to de-identified health events within PurpleLab’s platform.
This means marketers can assess outcomes such as:
- Prescription lift among exposed vs. unexposed audiences
- Healthcare professional engagement and treatment initiation
- Patient adherence or follow-through behavior
This type of closed-loop reporting is critical in pharma, where traditional metrics like clicks or impressions do not reflect business impact. Now, with token-based match-back, brands can see whether their campaigns are driving real results, securely and compliantly.
Ready to reach the right patients and providers securely and at scale?
Explore PurpleLab audiences in the Experian data marketplace and Audigent curated deals to activate clinically grounded, privacy-compliant segments across CTV, display, mobile, and more.
Contact us
Latest posts
Distribution via LiveRamp enables seamless cross-device customer experiences through more platforms NEW YORK, Nov. 15, 2016 /PRNewswire/ – Tapad, now part of Experian and the leading provider of unified cross-device marketing technology solutions, today announced an expanded partnership with LiveRamp™, an Acxiom® company and leading provider of omnichannel identity resolution, to make the proprietary Tapad Device Graph™ accessible beyond Tapad-hosted direct integrations. Through LiveRamp, Tapad's Device Graph Access now extends to more than 400 ad tech and mar tech platforms. Tapad's Device Graph™ enables marketers to understand, monetize and measure consumer engagement across all digital channels, and Tapad's unified consumer view is recognized as one of the most accurate, scalable cross-device solutions in the market today. Through the expanded partnership with LiveRamp, the Tapad Device Graph can be distributed to the hundreds of platforms used to reach consumers on digital channels and measure campaign performance – even as devices are added daily to Tapad's extensive graph. "Increasingly, marketers want access to cross-device targeting and measurement capabilities within their preferred platforms," said Anneka Gupta, chief product officer of LiveRamp. "Our expanded partnership makes it easy for marketers to access Tapad's graph through the rapidly growing set of integrations available in our partner ecosystem." This is the latest of several initiatives between the two technology platforms designed to make the integration of cross-screen platforms seamless, privacy-safe and easy to use for dynamic and engaging marketing efforts. "During the past year, Tapad has expanded its global presence and rapidly grown its data business – Tapad Coral – doubling the number of companies integrating our device graph into their platforms and growing our annualized run rate by 210%," said Pierre Martensson, GM of Tapad Coral and APAC. "Our expanded partnership with LiveRamp positions us to meet the increased demand for Tapad Device Graph Access and enable new platforms to apply our graph with unprecedented speed." Contact us today
Cross-Screen Pioneer Explores the Power of Connected Cars as a Vehicle for Customer Engagement LAS VEGAS, NV — (October 26, 2016) –Kate O’Loughlin, GM of Media for Tapad, addressed the J.D. Power Automotive conference audience today in Las Vegas, NV. With more than 1,400 participants representing every facet of the automotive marketing profession, the conference has become the industry's leading marketing event. Bringing the unified, cross-screen perspective to the stage, O’Loughlin discussed the vital role of connected cars in the consumer engagement process. She is a founding member of Tapad which launched the world’s first cross-screen marketing technology in 2010. Tapad was acquired by the Telenor Group early in 2016. Key points from O’Loughlin’s J.D. Power 2016 address included: The marketers who deliver relevant and engaging content in a privacy-safe setting will be in the strongest position to navigate the proliferation of connected devices, including the connected points in cars. As automakers innovate the technology in cars, marketers need to be prepared for the size and diversity of data available for understanding consumers. It’s going to be increasingly difficult to wade through the data, so now is the time to build a solid framework for understanding the person behind the data. Marketers who evolve — and take a holistic approach — to their campaign measurements will achieve marked improvements in efficiency and an enhanced understanding of their core audiences. Actionable brand engagement metrics like Viewable Exposure Time (VET) will continue to overtake traditional advertising performance metrics. VET evaluates the optimal amount of time an ad is present on a screen to incite consumer action. In early testing by Tapad, campaigns that employ VET see conversion rate performance improvements from 13 to 60%. The consumer-centric technology solutions of the future need to be as scalable as they are affordable. Learn more about Tapads’ recommended Viewable Exposure Time metric contact us today! Contact us today
NEW YORK, Sept. 28, 2016 /PRNewswire/ – Tapad, the leader in cross-device marketing technology, today announced a new metric for cross-device marketers, Viewable Exposure Time (VET). Viewable Exposure Time measures across screens and ad formats, identifying the optimal amount of time a consumer spends with an ad before they take action. The announcement coincides with Unify Tech '16, Tapad's third-annual cross-device summit during Advertising Week NY. Frequency caps are currently used to ensure that dollars aren't wasted on redundant ads. Viewable Exposure Time evolves the frequency capping approach to include accelerating a consumer's ad exposure rate up to the optimal time spent with the brand. VET is used in affinity, digital transaction and offline purchase models as a key indicator of marketing budget well-spent. Beta users of VET span every vertical, though interest is especially high from CPG, Automotive, Telecommunications and Retail. Viewable Exposure Time unifies and upgrades marketers' predictors of advertising success by leveraging cross-screen engagement across digital and television, with vendor-agnostic viewability scores for video, rich media and display. "Today's current measurement options, like click-through rate (CTR) and TV gross ratings points (GRP) tell an incomplete story," said Tapad GM of Media Kate O'Loughlin. "Tapad is focused on measuring what really matters to marketers – building an efficient connection with a customer. Innovation in metrics was long overdue." More than just a measurement tool, Tapad also provides clients with VET activation. Factoring in time spent with ads in viewable seconds and minutes, these analytics inform marketers about which audiences are underexposed, enabling them to adjust campaigns and deliver according to optimal viewable exposure time. This effectively increases conversion rates at the lowest cost. Contact us today